1
|
Konieczna-Wolska K, Caratis F, Opiełka M, Biernacki K, Urbanowicz K, Klimaszewska J, Pobiarzyn P, Krajewski O, Demkowicz S, Smoleński RT, Karaszewski B, Seuwen K, Rutkowska A. Accelerated remyelination and immune modulation by the EBI2 agonist 7α,25-dihydroxycholesterol analogue in the cuprizone model. Biomed Pharmacother 2024; 181:117653. [PMID: 39489122 DOI: 10.1016/j.biopha.2024.117653] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2024] [Revised: 10/15/2024] [Accepted: 10/28/2024] [Indexed: 11/05/2024] Open
Abstract
Research indicates a role for EBI2 receptor in remyelination, demonstrating that its deficiency or antagonism inhibits this process. However, activation of EBI2 with its endogenous ligand, oxysterol 7α,25-dihydroxycholesterol (7α,25OHC), does not enhance remyelination beyond the levels observed in spontaneously remyelinating tissue. We hypothesized that the short half-life of the natural ligand might explain this lack of beneficial effects and tested a synthetic analogue, CF3-7α,25OHC, in the cuprizone model. The data showed that extending the bioavailability of 7α,25OHC is sufficient to accelerate remyelination in vivo. Moreover, the analogue, in contrast to the endogenous ligand, upregulated brain expression of Ebi2 and the synthesis of 15 lipids in the mouse corpus callosum. Mechanistically, the increased concentration of oxysterol likely disrupted its gradient in demyelinated areas of the brain, leading to the dispersion of infiltrating EBI2-expressing immune cells rather than their accumulation in demyelinated regions. Remarkably, the analogue CF3-7α,25OHC markedly decreased the lymphocyte and monocyte counts mimicking the key mechanism of action of some of the most effective disease-modifying therapies for multiple sclerosis. Furthermore, the Cd4+ transcripts in the cerebellum and CD4+ cell number in the corpus callosum were reduced compared to vehicle-treated mice. These findings suggest a mechanism by which EBI2/7α,25OHC signalling modulates the immune response and accelerates remyelination in vivo.
Collapse
Affiliation(s)
- Klaudia Konieczna-Wolska
- Brain Diseases Centre, Medical University of Gdańsk, Gdańsk, Poland; Tri-City Central Animal Laboratory Research and Service Center, Medical University of Gdańsk, Gdańsk, Poland
| | - Fionä Caratis
- Department of Anatomy and Neurobiology, Medical University of Gdańsk, Gdańsk, Poland; Department of Biochemistry, Medical University of Gdańsk, Gdańsk, Poland
| | - Mikołaj Opiełka
- Brain Diseases Centre, Medical University of Gdańsk, Gdańsk, Poland; Department of Biochemistry, Medical University of Gdańsk, Gdańsk, Poland
| | - Karol Biernacki
- Department of Organic Chemistry, Gdańsk University of Technology, Gdańsk, Poland
| | | | - Joanna Klimaszewska
- Department of Laboratory Medicine, Medical University of Gdańsk, Gdańsk, Poland
| | - Piotr Pobiarzyn
- Brain Diseases Centre, Medical University of Gdańsk, Gdańsk, Poland
| | - Oliwier Krajewski
- Department of Anatomy and Neurobiology, Medical University of Gdańsk, Gdańsk, Poland
| | - Sebastian Demkowicz
- Department of Organic Chemistry, Gdańsk University of Technology, Gdańsk, Poland
| | | | - Bartosz Karaszewski
- Brain Diseases Centre, Medical University of Gdańsk, Gdańsk, Poland; Department of Adult Neurology, Medical University of Gdańsk and University Clinical Center, Gdańsk, Poland
| | - Klaus Seuwen
- Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
| | - Aleksandra Rutkowska
- Brain Diseases Centre, Medical University of Gdańsk, Gdańsk, Poland; Department of Anatomy and Neurobiology, Medical University of Gdańsk, Gdańsk, Poland.
| |
Collapse
|
2
|
Zhou S, Zheng Y, Yang B, Zhong J, Shi H. Study on synthesis of key squalamine intermediate 7α, 24R-dihydroxy-5α-cholestan-3-one. Steroids 2019; 151:108472. [PMID: 31400392 DOI: 10.1016/j.steroids.2019.108472] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/10/2019] [Revised: 07/30/2019] [Accepted: 08/02/2019] [Indexed: 12/01/2022]
Abstract
A facile novel strategy has been developed to obtain a key intermediate of squalamine, 7α, 24R -dihydroxy-5α-cholestan-3-one, starting from methyl Δ5-3β-hydroxycholanate. The pure product was successfully synthesized and separated from the C-24 position epimers in good purity, d.e.% and yield.
Collapse
Affiliation(s)
- Shuai Zhou
- College of Chemical Engineering, Nanjing Tech University, Nanjing, Jiangsu 210009, PR China
| | - Yang Zheng
- College of Chemical Engineering, Nanjing Tech University, Nanjing, Jiangsu 210009, PR China
| | - Beibei Yang
- College of Chemical Engineering, Nanjing Tech University, Nanjing, Jiangsu 210009, PR China
| | - Jiawei Zhong
- College of Chemical Engineering, Nanjing Tech University, Nanjing, Jiangsu 210009, PR China
| | - Haijian Shi
- College of Chemical Engineering, Nanjing Tech University, Nanjing, Jiangsu 210009, PR China.
| |
Collapse
|
3
|
Deng X, Sun S, Wu J, Kuei C, Joseph V, Liu C, Mani NS. Fluoro analogs of bioactive oxy-sterols: Synthesis of an EBI2 agonist with enhanced metabolic stability. Bioorg Med Chem Lett 2016; 26:4888-4891. [DOI: 10.1016/j.bmcl.2016.09.029] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2016] [Revised: 09/08/2016] [Accepted: 09/10/2016] [Indexed: 11/24/2022]
|
4
|
Total Synthesis of Limonin. Angew Chem Int Ed Engl 2015; 54:8538-41. [DOI: 10.1002/anie.201503794] [Citation(s) in RCA: 63] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2015] [Revised: 05/16/2015] [Indexed: 11/07/2022]
|
5
|
Yamashita S, Naruko A, Nakazawa Y, Zhao L, Hayashi Y, Hirama M. Total Synthesis of Limonin. Angew Chem Int Ed Engl 2015. [DOI: 10.1002/ange.201503794] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
6
|
Hannedouche S, Zhang J, Yi T, Shen W, Nguyen D, Pereira JP, Guerini D, Baumgarten BU, Roggo S, Wen B, Knochenmuss R, Noël S, Gessier F, Kelly LM, Vanek M, Laurent S, Preuss I, Miault C, Christen I, Karuna R, Li W, Koo DI, Suply T, Schmedt C, Peters EC, Falchetto R, Katopodis A, Spanka C, Roy MO, Detheux M, Chen YA, Schultz PG, Cho CY, Seuwen K, Cyster JG, Sailer AW. Oxysterols direct immune cell migration via EBI2. Nature 2011; 475:524-7. [PMID: 21796212 PMCID: PMC4297623 DOI: 10.1038/nature10280] [Citation(s) in RCA: 358] [Impact Index Per Article: 25.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2010] [Accepted: 06/09/2011] [Indexed: 12/20/2022]
Abstract
Epstein-Barr virus-induced gene 2 (EBI2, also known as GPR183) is a G-protein-coupled receptor that is required for humoral immune responses; polymorphisms in the receptor have been associated with inflammatory autoimmune diseases. The natural ligand for EBI2 has been unknown. Here we describe the identification of 7α,25-dihydroxycholesterol (also called 7α,25-OHC or 5-cholesten-3β,7α,25-triol) as a potent and selective agonist of EBI2. Functional activation of human EBI2 by 7α,25-OHC and closely related oxysterols was verified by monitoring second messenger readouts and saturable, high-affinity radioligand binding. Furthermore, we find that 7α,25-OHC and closely related oxysterols act as chemoattractants for immune cells expressing EBI2 by directing cell migration in vitro and in vivo. A critical enzyme required for the generation of 7α,25-OHC is cholesterol 25-hydroxylase (CH25H). Similar to EBI2 receptor knockout mice, mice deficient in CH25H fail to position activated B cells within the spleen to the outer follicle and mount a reduced plasma cell response after an immune challenge. This demonstrates that CH25H generates EBI2 biological activity in vivo and indicates that the EBI2-oxysterol signalling pathway has an important role in the adaptive immune response.
Collapse
Affiliation(s)
| | - Juan Zhang
- Analytical Sciences; Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Tangsheng Yi
- Howard Hughes Medical Institute and Department of Microbiology and Immunology, University of California San Francisco, CA, USA
| | - Weijun Shen
- Genomics Institute of the Novartis Research Foundation, San Diego, CA, USA
- Department of Chemistry, The Scripps Research Institute, La Jolla, CA, USA
| | - Deborah Nguyen
- Genomics Institute of the Novartis Research Foundation, San Diego, CA, USA
| | - João P. Pereira
- Howard Hughes Medical Institute and Department of Microbiology and Immunology, University of California San Francisco, CA, USA
| | - Danilo Guerini
- Autoimmunity, Transplantation and Inflammation; Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Birgit U. Baumgarten
- Developmental and Molecular Pathways; Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Silvio Roggo
- Global Discovery Chemistry; Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Ben Wen
- Genomics Institute of the Novartis Research Foundation, San Diego, CA, USA
| | - Richard Knochenmuss
- Analytical Sciences; Novartis Institutes for BioMedical Research, Basel, Switzerland
| | | | - Francois Gessier
- Global Discovery Chemistry; Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Lisa M. Kelly
- Howard Hughes Medical Institute and Department of Microbiology and Immunology, University of California San Francisco, CA, USA
| | - Mirka Vanek
- Developmental and Molecular Pathways; Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Stephane Laurent
- Developmental and Molecular Pathways; Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Inga Preuss
- Developmental and Molecular Pathways; Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Charlotte Miault
- Global Discovery Chemistry; Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Isabelle Christen
- Analytical Sciences; Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Ratna Karuna
- Analytical Sciences; Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Wei Li
- Genomics Institute of the Novartis Research Foundation, San Diego, CA, USA
| | - Dong-In Koo
- Department of Chemistry, The Scripps Research Institute, La Jolla, CA, USA
| | - Thomas Suply
- Developmental and Molecular Pathways; Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Christian Schmedt
- Genomics Institute of the Novartis Research Foundation, San Diego, CA, USA
| | - Eric C. Peters
- Genomics Institute of the Novartis Research Foundation, San Diego, CA, USA
| | - Rocco Falchetto
- Analytical Sciences; Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Andreas Katopodis
- Autoimmunity, Transplantation and Inflammation; Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Carsten Spanka
- Global Discovery Chemistry; Novartis Institutes for BioMedical Research, Basel, Switzerland
| | | | | | - Yu Alice Chen
- Genomics Institute of the Novartis Research Foundation, San Diego, CA, USA
| | - Peter G. Schultz
- Genomics Institute of the Novartis Research Foundation, San Diego, CA, USA
| | - Charles Y. Cho
- Genomics Institute of the Novartis Research Foundation, San Diego, CA, USA
| | - Klaus Seuwen
- Developmental and Molecular Pathways; Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - Jason G. Cyster
- Howard Hughes Medical Institute and Department of Microbiology and Immunology, University of California San Francisco, CA, USA
| | - Andreas W. Sailer
- Developmental and Molecular Pathways; Novartis Institutes for BioMedical Research, Basel, Switzerland
- Corresponding author: Andreas W. Sailer, Ph. D. Developmental & Molecular Pathways Novartis Institutes for BioMedical Research Forum 1, Novartis Campus, WSJ-355.4.025.8 4056 Basel, Switzerland Phone: +41 79 5500941 Fax: +41 61 6968714
| |
Collapse
|
7
|
Liu C, Yang XV, Wu J, Kuei C, Mani NS, Zhang L, Yu J, Sutton SW, Qin N, Banie H, Karlsson L, Sun S, Lovenberg TW. Oxysterols direct B-cell migration through EBI2. Nature 2011; 475:519-23. [PMID: 21796211 DOI: 10.1038/nature10226] [Citation(s) in RCA: 288] [Impact Index Per Article: 20.6] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2011] [Accepted: 05/17/2011] [Indexed: 12/31/2022]
Abstract
EBI2 (also called GPR183) is an orphan G-protein-coupled receptor that is highly expressed in spleen and upregulated upon Epstein-Barr-virus infection. Recent studies indicated that this receptor controls follicular B-cell migration and T-cell-dependent antibody production. Oxysterols elicit profound effects on immune and inflammatory responses as well as on cholesterol metabolism. The biological effects of oxysterols have largely been credited to the activation of nuclear hormone receptors. Here we isolate oxysterols from porcine spleen extracts and show that they are endogenous ligands for EBI2. The most potent ligand and activator is 7α,25-dihydroxycholesterol (OHC), with a dissociation constant of 450 pM for EBI2. In vitro, 7α,25-OHC stimulated the migration of EBI2-expressing mouse B and T cells with half-maximum effective concentration values around 500 pM, but had no effect on EBI2-deficient cells. In vivo, EBI2-deficient B cells or normal B cells desensitized by 7α,25-OHC pre-treatment showed reduced homing to follicular areas of the spleen. Blocking the synthesis of 7α,25-OHC in vivo with clotrimazole, a CYP7B1 inhibitor, reduced the content of 7α,25-OHC in the mouse spleen and promoted the migration of adoptively transferred pre-activated B cells to the T/B boundary (the boundary between the T-zone and B-zone in the spleen follicle), mimicking the phenotype of pre-activated B cells from EBI2-deficient mice. Our results show an unexpected causal link between EBI2, an orphan G-protein-coupled receptor controlling B-cell migration, and the known immunological effects of certain oxysterols, thus uncovering a previously unknown role for this class of molecules.
Collapse
Affiliation(s)
- Changlu Liu
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C., 3210 Merryfield Row, San Diego, California 92121, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Poza JJ, Jiménez C, Rodríguez J. J-Based Analysis and DFT-NMR Assignments of Natural Complex Molecules: Application to 3β,7-Dihydroxy-5,6-epoxycholestanes. European J Org Chem 2008. [DOI: 10.1002/ejoc.200800358] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
9
|
Antonchick AV, Zhabinskii VN, Khripach VA. Synthesis of sterols oxygenated in the terminal fragment of their side chains. RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY 2008. [DOI: 10.1134/s1068162008040018] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
10
|
Choi H, Doyle MP. Optimal TBHP allylic oxidation of Delta5-steroids catalyzed by dirhodium caprolactamate. Org Lett 2007; 9:5349-52. [PMID: 18027961 PMCID: PMC2596589 DOI: 10.1021/ol7025284] [Citation(s) in RCA: 54] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
Dirhodium caprolactamate is the most efficient catalyst for the oxidation of Delta5-steroids to 7-keto-Delta5-steroids by 70% tert-butyl hydroperoxide in water (T-HYDRO). Isolated product yields range from 38 to 87%.
Collapse
Affiliation(s)
- Hojae Choi
- Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland 20742
| | - Michael P. Doyle
- Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland 20742
| |
Collapse
|
11
|
Poza J, Rega M, Paz V, Alonso B, Rodríguez J, Salvador N, Fernández A, Jiménez C. Synthesis and evaluation of new 6-hydroximinosteroid analogs as cytotoxic agents. Bioorg Med Chem 2007; 15:4722-40. [PMID: 17531494 DOI: 10.1016/j.bmc.2007.05.003] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2006] [Revised: 04/25/2007] [Accepted: 05/02/2007] [Indexed: 11/21/2022]
Abstract
Taking into account the structural requirements for cytotoxicity, several new hydroximinosteroid derivatives have been prepared and evaluated for their cytotoxic activity against A-549, H116, PSN1, and T98G cultured tumor cell lines in order to obtain further information on the potential pharmacophoric core of this type of compound. The influence of the oxygenated position in the A ring, the presence of an additional oxygenated position at C-7 and C-16, and a fluorinated position at C-5 were considered in order to study the structure-activity relationships. The results reveal the importance of oxygenated positions in the A ring (e.g., 4,5-epoxide showed an IC50 value against HCT-116 under micromolar level) for an increase in cytotoxic activity in this type of compound. Furthermore, they showed an important selectivity toward colon tumor line (HCT-116).
Collapse
Affiliation(s)
- Javier Poza
- Departamento de Química Fundamental, Facultade de Ciencias, Universidade de A Coruña, Campus da Zapateira, 15071 A Coruña, Spain
| | | | | | | | | | | | | | | |
Collapse
|